Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disease characterized clinically by progressive weakness and neuropathologically by nuclear loss and cytoplasmic aggregation of the RNA binding protein TDP-43 in neurons of the brain and spinal cord in > 97% of cases [6]. Here, TARDBP is linked to amyotrophic lateral sclerosis.